Correction to "Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment".

ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to “Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment”Shakir Ahamad*Shakir AhamadMore by Shakir Ahamadhttps://orcid.org/0000-0002-9873-7806 and Shahnawaz A. Bhat*Shahnawaz A. BhatMore by Shahnawaz A. BhatCite this: J. Med. Chem. 2023, 66, 13, 9227–9228Publication Date (Web):June 28, 2023Publication History Received20 June 2023Published online28 June 2023Published inissue 13 July 2023https://doi.org/10.1021/acs.jmedchem.3c01112Copyright © 2023 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views559Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (1 MB) Get e-Alertsclose Get e-Alerts